Olmesartan Medoxomil and Rosuvastatin Tablets 20/10mg

Adult dose

Olmesartan Medoxomil: The recommended initial dose is 10 mg once daily, taken regardless of meals. If blood pressure is not adequately controlled, the dose may be increased to 20 mg once daily, with a maximum of 40 mg per day. The blood pressure-lowering effect appears within 2 weeks of treatment initiation and reaches its maximum effect in about 8 weeks. If blood pressure control is inadequate with this medication alone, it may be combined with thiazide diuretics.

Child dose

Safety and efficacy in patients under the age of 18 have not been established.

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. It should not be administered to women who are allergic to this medicine, pregnant or breastfeeding, or to women of childbearing potential who are not using effective contraceptive methods. Avoid use in patients with severely impaired kidney function or liver function, those with biliary obstruction, or those with muscular diseases. Patients with genetic issues related to any of the components of this medication should not take it. Patients with very low blood pressure or reduced body sodium or blood volume may experience hypotension symptoms during the initial phase of treatment, and should be closely monitored. Patients with diminished kidney function or kidney transplant patients should regularly undergo blood tests to check kidney function and electrolyte status. Patients at risk for hyperkalemia should have their blood potassium levels monitored periodically, and caution is also warranted for patients with heart or cardiovascular disease. If symptoms such as muscle pain, weakness, or cramps occur during treatment, consult a doctor immediately. Liver function abnormalities may occur, so regular liver function tests before and during treatment are recommended. This medication may interact with other drugs, so inform your doctor or pharmacist if you are taking other medications. Women who are pregnant or planning to become pregnant should avoid taking this medication, and should stop immediately if pregnancy is confirmed during treatment, using effective contraceptive methods. Breastfeeding women should also stop breastfeeding or discontinue this medication as it may affect the baby. The safety and efficacy in children under 18 years of age have not been established, and its use is not recommended. Elderly patients may require dose adjustments and monitoring due to increased drug concentration in the body. In case of overdose, symptoms such as hypotension and arrhythmias may occur, and immediate medical attention is necessary. This medication should be stored out of reach of children and must not be transferred to other containers.

Serious side effects

Urticaria, severe swelling (edema), angioedema, tightness in the chest, difficulty breathing, cold sweats, pallor, severe allergic reactions, severe rash with high fever, blisters, exfoliative skin reactions, mucosal pain in the mouth/eyes, severe skin reactions, difficulty breathing or shortness of breath, asthmatic attacks, respiratory abnormalities with cough and fever, breathing problems, yellowing of the skin or eyes (jaundice), profound lethargy, liver abnormalities (jaundice)

Mild side effects

• Headache
• dizziness
• sensory impairment
• drowsiness
• gastroesophageal reflux disease
• constipation
• dental caries
• dyspepsia
• gastric ulcers
• gastritis

This medication should be stored in a tightly sealed container to protect it from air and moisture, at a temperature between 1 degree and 30 degrees Celsius. Storing it this way will help maintain its effectiveness and prevent degradation.

Appearance

White or yellowish round film-coated tablets

Package unit

30 tablets/box [30 tablets ((10 tablets/Alu-Alu) X 3)]